AdvisorShares Investments’s Teva Pharmaceuticals TEVA Stock Holding History

AdvisorShares Investments’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.1M	Sell	36,431 -369	-1%	-$11.9K	0.2%	73
2025 Q4	$1.15M	Buy	+36,800	New	+$907K	0.19%	72
2025 Q2	–	Sell	-43,182	Closed	-$660K	–	332
2025 Q1	$660K	Buy	43,182 +14,486	+50%	+$259K	0.13%	87
2024 Q4	$632K	Sell	28,696 -4,220	-13%	-$76.8K	0.12%	72
2024 Q3	$593K	Buy	+32,916	New	+$576K	0.11%	75

Other funds holding TEVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AdvisorShares Investments's TEVA Position: Q1 2026 in Review

AdvisorShares Investments reduced its Teva Pharmaceuticals (TEVA) stake by 1% in Q1 2026, selling an estimated $11.9K and leaving 36,431 shares worth $1.1M. The position accounts for 0.2% of the portfolio, ranked #73.

AdvisorShares Investments first reported a position in TEVA in Q3 2024 and has held it in 5 quarters since. The position peaked at $1.15M in Q4 2025. 650 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

AdvisorShares Investments held 36,431 shares of Teva Pharmaceuticals worth $1.1M as of Q1 2026.
AdvisorShares Investments sold 369 Teva Pharmaceuticals shares in Q1 2026, an estimated $11.9K.
Teva Pharmaceuticals made up 0.2% of AdvisorShares Investments's portfolio in Q1 2026, its #73 holding.
AdvisorShares Investments first reported a position in Teva Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
AdvisorShares Investments's Teva Pharmaceuticals position peaked at $1.15M in Q4 2025.
650 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on AdvisorShares Investments's 13F filing for Q1 2026, filed 28 Apr 2026.